Clinical Trial Update: Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing carbon ion radiotherapy for patients with oligometastatic prostate cancer who are receiving systemic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Shanghai Proton and Heavy Ion Center | Conditions: Metastatic Prostate Carcinoma | Phase 2 | Status: UNKNOWN